Dicerna Pharmaceuticals Inc (DRNA) Stock News
NASDAQ:DRNA - Nasdaq - Common Stock
DRNA Latest News, Press Relases and Analysis
Aligos Therapeutics Strengthens Senior Leadership Team with the Appointment of Hardean Achneck, MD as Chief Medical Officer
Eli Lilly Just Lent Its Big Pharma Cachet To Verve's Nascent Gene-Editing Program For $60 Million
Eli Lilly inked a deal worth $60 million to get in on a gene-editing drug for elevated lipoprotein A.
Novo Nordisk Announces Completion of Dicerna Pharmaceuticals Acquisition
Dicerna Announces Expiration of Hart-Scott-Rodino Act Waiting Period for Novo Nordisk Tender Offer to Acquire Dicerna
SHAREHOLDER INVESTIGATION: Halper Sadeh LLP Investigates the Following Companies - ROG, PAE, MNTV, CSPR, VLY, DRNA
/PRNewswire/ -- Halper Sadeh LLP, a global investor rights law firm, announces it is investigating the following companies: Rogers Corporation (NYSE: ROG)...
10 Biggest Price Target Changes For Thursday
SVB Leerink boosted the price target on Edwards Lifesciences Corporation (NYSE:
Benzinga's Top Ratings Upgrades, Downgrades For December 9, 2021
Upgrades According to BMO Capital, the prior rating for Nuvei Corp (NASDAQ:
SHAREHOLDER ALERT: WeissLaw LLP Reminds VG, DRNA, DVD, and COR Shareholders About Its Ongoing Investigations
/PRNewswire/ -- If you own shares in any of the companies listed above and would like to discuss our investigations or have any questions concerning this...
SHAREHOLDER INVESTIGATION: Halper Sadeh LLP Investigates ADTN, ROG, VG, DRNA; Shareholders are Encouraged to Contact the Firm
/PRNewswire/ -- Halper Sadeh LLP, a global investor rights law firm, announces it is investigating the following companies: ADTRAN, Inc. (NASDAQ: ADTN)...
SHAREHOLDER ALERT: WeissLaw LLP Reminds STXB, DRNA, DVD and VSAT Shareholders About Its Ongoing Investigations
/PRNewswire/ -- If you own shares in any of the companies listed above and would like to discuss our investigations or have any questions concerning this...
SHAREHOLDER INVESTIGATION: Halper Sadeh LLP Investigates CONE, VLY, DRNA, CSPR; Shareholders are Encouraged to Contact the Firm
/PRNewswire/ -- Halper Sadeh LLP, a global investor rights law firm, announces it is investigating the following companies: CyrusOne Inc. (NASDAQ: CONE)...
SHAREHOLDER ALERT: WeissLaw LLP Reminds DRNA, IHC, NE, and ABTX Shareholders About Its Ongoing Investigations
/PRNewswire/ -- If you own shares in any of the companies listed above and would like to discuss our investigations or have any questions concerning this...
4 Reasons Arrowhead Pharmaceuticals Could Be the Next Biotech Buyout
The recent acquisition of Dicerna Pharmaceuticals makes Arrowhead Pharmaceuticals look like the next biotech in line to receive a juicy buyout offer.
SHAREHOLDER INVESTIGATION: Halper Sadeh LLP Investigates COR, STXB, BCML, DRNA; Shareholders are Encouraged to Contact the Firm
NEW YORK, NY / ACCESSWIRE / November 23, 2021 / Halper Sadeh LLP, a global investor rights law firm, announces it is investigating the following companies: CoreSite Realty Corporation (NYSE:COR) concerning potential violations of the federal securities laws and/or breaches of fiduciary duties relating to its sale to American Tower Corporation for $170.00 per share in cash.If you are a CoreSite shareholder, click here to learn more about your
SHAREHOLDER INVESTIGATION: Halper Sadeh LLP Investigates DRNA, RRD, LEVL, HRC; Shareholders are Encouraged to Contact the Firm
NEW YORK, NY / ACCESSWIRE / November 22, 2021 / Halper Sadeh LLP, a global investor rights law firm, announces it is investigating the following companies: Dicerna Pharmaceuticals, Inc. (NASDAQ:DRNA) concerning potential violations of the federal securities laws and/or breaches of fiduciary duties relating to its sale to Novo Nordisk for $38.25 per share in cash. If you are a Dicerna shareholder, click here to learn more about your rights and
How Alnylam Pharmaceuticals Could Take On Pfizer With A 'Catalyst-Rich' 2022
Alnylam is working on a drug that could tackle transthyretin cardiomyopathy.
SHAREHOLDER INVESTIGATION: Halper Sadeh LLP Investigates COR, DRNA, STXB, BCML; Shareholders are Encouraged to Contact the Firm
/PRNewswire/ --Halper Sadeh LLP, a global investor rights law firm, announces it is investigating the following companies: CoreSite Realty Corporation (NYSE:...
Novo Nordisk (NVO) Set to Acquire Dicerna for $3.3 Billion
Novo Nordisk (NVO) inks agreement to acquire Dicerna for $3.3 billion. The company is looking to boost its RNAi research platform with this acquisition.
SHAREHOLDER ALERT: WeissLaw LLP Investigates Dicerna Pharmaceuticals, Inc.
/PRNewswire/ -- WeissLaw LLP is investigating possible breaches of fiduciary duty and other violations of law by the board of directors of Dicerna...
Dicerna Pharmaceuticals acquired by Novo Nordisk; Shares rocket 80%
Gottlieb said on CNBC's "Squawk Box" the fastest way to get more immunity into the population ahead of holiday season is a booster shot.
Why Dicerna Pharmaceuticals Stock Is Rocketing Higher Today
A juicy buyout offer from Novo Nordisk is giving Dicerna shareholders a big reason to cheer.
Mentions: NVO
PTLO Stock: 8 Reasons Why Portillo’s Investors Feel Like Losing Their Lunch Today
Portillo's (PTLO) stock isn't doing so hot on Thursday and we're breaking down what has investors in the fast-food chain upset.
LCID, RIVN, FSR: Why Are EV Stocks Down Today?
We're taking a look at why EV stocks are down today and there are a couple of reasons shares of investors' favorites are falling.
Shareholder Alert: Ademi LLP investigates whether Dicerna Pharmaceuticals, Inc. has obtained a Fair Price in its going private transaction with Novo Nordisk
/PRNewswire/ -- Ademi LLP is investigating Dicerna (Nasdaq: DRNA), for possible breaches of fiduciary duty and other violations of law in its transaction with...
DRNA Stock: The $3B Novo Nordisk Deal That Has Dicerna Pharma Shares Skyrocketing Today
Dicerna Pharmaceuticals (DRNA) stock is surging higher on Thursday following news of a massive $3.3 billion deal with Novo Nordisk.
Dicerna Stock Rockets On Novo Nordisk's $3.3 Billion Takeover Plan
Novo Nordisk is buying an RNA interference company.